Western blot and histology data in Fig. 6E–G further depict the suppression of inflammatory (NF-kB), angiogenic (VEGF and CD31), and metastatic (MMP9) markers as well as induction of apoptosis (C-PARP) in the CRC tumour tissue of mice treated with FDMC as compared with vehicle-treated mice. This evidence concerns the gene NFKB1 and colorectal carcinoma.